Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Meredith

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
JACC. Cardiovascular Interventions|April 23, 2013
Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stentsDavid E Kandzari, Martin B Leon, Ian Meredith, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 9, 2015
Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I studyStephen Worthley, Randall Hendriks, Matthew Worthley, et al.
American Heart Journal|April 30, 2013
Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapyPhilip Urban, Alex Abizaid, Bernard Chevalier, et al.
American Heart Journal|June 25, 2004
Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trialPeter L Thompson, Ian Meredith, John Amerena, et al.
American Heart Journal|March 20, 2012
A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study)Dion Stub, Karen Smith, Stephen Bernard, et al.
American Heart Journal|June 5, 2017
A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR studySteven L Goldberg, Ian Meredith, Thomas Marwick, et al.
International Journal of Cardiology|June 6, 2017
Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trialMarie-Claude Morice, Suneel Talwar, Oliver Gaemperli, et al.
JACC. Cardiovascular Interventions|January 15, 2011
Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stentsLaura Mauri, Joseph M Massaro, Songtao Jiang, et al.
Cardiovascular Research|July 17, 2012
Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarctionJonathon Habersberger, Frederik Strang, Amelie Scheichl, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2014
Performance of the resolute zotarolimus-eluting stent in small vesselsRonald Caputo, Martin Leon, Patrick Serruys, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
JACC. Cardiovascular Interventions|April 23, 2013
Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stentsDavid E Kandzari, Martin B Leon, Ian Meredith, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 9, 2015
Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I studyStephen Worthley, Randall Hendriks, Matthew Worthley, et al.
American Heart Journal|April 30, 2013
Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapyPhilip Urban, Alex Abizaid, Bernard Chevalier, et al.
American Heart Journal|June 25, 2004
Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trialPeter L Thompson, Ian Meredith, John Amerena, et al.
American Heart Journal|March 20, 2012
A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study)Dion Stub, Karen Smith, Stephen Bernard, et al.
American Heart Journal|June 5, 2017
A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR studySteven L Goldberg, Ian Meredith, Thomas Marwick, et al.
International Journal of Cardiology|June 6, 2017
Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trialMarie-Claude Morice, Suneel Talwar, Oliver Gaemperli, et al.
JACC. Cardiovascular Interventions|January 15, 2011
Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stentsLaura Mauri, Joseph M Massaro, Songtao Jiang, et al.
Cardiovascular Research|July 17, 2012
Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarctionJonathon Habersberger, Frederik Strang, Amelie Scheichl, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2014
Performance of the resolute zotarolimus-eluting stent in small vesselsRonald Caputo, Martin Leon, Patrick Serruys, et al.
Pageof 5